|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 1.65B 1.44B 1.34B 1.23B 2.32B 159B 2.35B 15.97B 6.26B 77.76B 6.19B 6.05B 268B | P/E 2026 * |
14.9x | P/E 2027 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.81B 1.58B 1.46B 1.35B 2.54B 174B 2.58B 17.5B 6.86B 85.22B 6.78B 6.63B 294B | EV / Sales 2026 * |
1.61x | EV / Sales 2027 * | 1.27x |
| Free-Float |
86.6% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biosante Pharmaceuticals Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Nikhil Lalwani
CEO | Chief Executive Officer | 48 | 2020-09-07 |
Stephen Carey
DFI | Director of Finance/CFO | 55 | 2016-05-05 |
Elizabeth Powell
CMP | Compliance Officer | - | 2022-02-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Haughey
CHM | Chairman | 62 | 2025-11-23 |
Antonio Pera
BRD | Director/Board Member | 68 | 2020-08-05 |
Jeanne A. Thoma
BRD | Director/Board Member | 66 | 2020-08-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.73% | -2.96% | +48.62% | +147.27% | 1,051B | |
| -1.67% | -3.47% | +52.00% | +47.77% | 609B | |
| -0.44% | +2.17% | +33.88% | +78.20% | 450B | |
| -0.75% | +0.30% | +28.32% | +21.15% | 330B | |
| -1.52% | -1.19% | +33.38% | +35.35% | 284B | |
| -1.70% | -1.82% | +20.26% | +15.74% | 263B | |
| -0.58% | +1.11% | -20.89% | -40.59% | 223B | |
| -0.58% | +1.03% | +23.55% | +56.14% | 198B | |
| -0.80% | +1.38% | +23.09% | +66.64% | 167B | |
| Average | -0.76% | -0.16% | +26.91% | +47.52% | 397.23B | |
| Weighted average by Cap. | -0.89% | -1.08% | +35.25% | +70.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.12B 983M 909M 836M 1.58B 108B 1.6B 10.87B 4.26B 52.93B 4.21B 4.12B 182B | 1.24B 1.09B 1.01B 925M 1.75B 120B 1.77B 12.03B 4.72B 58.6B 4.66B 4.56B 202B |
| Net income | 117M 103M 94.91M 87.29M 165M 11.3B 167M 1.13B 445M 5.53B 440M 430M 19.04B | 175M 153M 142M 130M 246M 16.86B 250M 1.69B 664M 8.25B 656M 642M 28.42B |
| Net Debt | 158M 139M 128M 118M 222M 15.26B 226M 1.53B 601M 7.46B 594M 581M 25.72B | -71.49M -62.66M -57.92M -53.27M -101M -6.89B -102M -693M -271M -3.37B -268M -263M -11.62B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
